Gene Editing Shows Promise for universal Blood Production

Quebec City – Researchers have demonstrated the potential to produce red blood cells ⁤in⁣ the lab that could be universally compatible, offering hope for patients with rare blood types⁣ or those requiring frequent transfusions.

CRISPR Technology Targets Blood Antigens

A study ⁣published ‍in Human Molecular Genetics details how a team from Laval University and Héma-Québec utilized CRISPR-Cas gene editing to modify red⁢ blood cell precursors. The goal was to inactivate genes responsible for specific antigens ⁢on the cell⁣ surface, which determine blood type compatibility.

“Blood compatibility hinges on antigenic molecules present on red blood cells,” explained Yannick Doyon, a professor⁤ at Laval University and researcher at the Research Center⁢ of the Quebec CHU – laval University. “While the ABO and Rh systems are well-known,numerous other antigen systems exist,making it challenging to find perfectly matched donors for individuals with‍ rare blood types or complex medical needs.”

Creating “Gold Blood”

The research focused on precursor cells from bone marrow, the source of red blood cells. By employing CRISPR-Cas, scientists successfully inactivated genes associated with the production of antigens found in HR+ and AS blood types.

“We thus manage to produce ‘gold blood’, without HR antigen+, and blood O-, compatible with all ⁢blood groups. The globules conversion rate is not yet 100%, but it is vrey ‍high.”

— Yannick Doyon, Laval university

Next Steps: Scaling Up production

Having established the feasibility of creating customized red blood cell lines, the research team ⁢is now focused on developing methods ⁤to produce these cells in sufficient quantities for clinical transfusions.

“We are working on the growth of an in vitro technique thanks to which we manage to differentiate from the⁤ precurs cells of red blood cells in mature red blood cells and ⁣to multiply them,” Doyon said. “These⁤ advances are approaching‍ even more about⁤ the production of genetically modified red blood cells with compatibility desired characteristics ⁣that could be used for ‍blood transfusions or research.”

Study ⁢Details

Yelena Boccacci, from Laval University and Héma-Québec, is the first author of the study. Other⁣ contributors include Yannick doyon, Nellie Dumont, and Josée Laganière.

Gene Editing and Universal Blood Production: Your‍ Questions Answered

What is the main goal of⁢ the ⁢research ⁢discussed in this article?

the primary aim of⁣ the⁤ research is to develop the capability to produce red ⁢blood cells in a lab setting that are universally compatible, potentially helping patients with rare ⁣blood types or those requiring frequent transfusions.

How are scientists attempting to create universal‍ blood?

Researchers are using CRISPR-Cas gene editing technology to modify red blood cell precursors. The focus is⁤ on inactivating genes responsible for specific antigens⁣ on⁣ the cell surface. These antigens determine blood type compatibility.

What is CRISPR-Cas gene editing?

CRISPR-Cas is a powerful gene editing⁢ tool. It⁤ allows scientists to precisely target and modify genes within DNA. In this research,⁤ it’s⁣ used to alter the genes responsible for the production of certain antigens on red blood cells.

Why is blood type compatibility so crucial?

Blood compatibility is critical because of the antigens present on red blood⁢ cells. if a patient receives blood with incompatible ⁤antigens, ‍their immune system may attack the transfused cells, potentially leading ⁣to serious health complications, including organ failure or death.

What are antigens?

Antigens ⁣are like ⁢unique identifiers on the surface of red blood cells. They trigger⁢ an immune response if they‍ are not recognized as belonging to the recipient’s body.

What are the main ⁢blood group systems that are targeted?

The article mentions that the research focuses on inactivating genes associated with the production of antigens found in HR+ and AS blood types.

What‍ is “gold blood”?

“Gold blood” is a term used by⁢ researchers (specifically,Yannick Doyon),to describe the result of this gene editing. It refers to blood without HR antigens,resembling O- blood,and is compatible with all blood groups.

How does this research relate to blood transfusions?

This ‍research⁤ aims for genetically modified red blood⁤ cells that can ⁣be used for blood transfusions, potentially ⁢overcoming the ⁤complexities of matching specific blood ‍types. This woudl greatly benefit patients with ⁤rare blood types who have trouble finding matching donors.

What ‍are ⁣the next steps ⁣in this research?

The research team is now concentrating on scaling up the ⁣production of these customized red blood cell lines to create sufficient quantities for ⁣clinical transfusions. They are focusing on developing an⁤ in vitro technique to differentiate precursor cells into mature red blood‍ cells and multiply them.

Who are the key ⁤researchers⁣ involved in this study?

The main contributors to the study are:

⁤Yelena Boccacci (first author)

‍ Yannick doyon

⁤ Nellie Dumont

Josée Laganière

Where was this research conducted?

The research was conducted by⁣ a team from Laval University and Héma-Québec, located in Quebec City.

What are the potential benefits of creating universal blood?

The benefits include:

⁢ Easier access to blood transfusions⁤ for patients with rare blood types.

Reduced risk of transfusion reactions ⁤due to better⁤ compatibility.

* Potential for use in‍ major patient populations requiring frequent transfusions.

What is the current conversion rate of producing ‍”gold ‍blood”?

The ⁣article states that the globules conversion rate is not yet 100%, but it is “very high”, per Yannick ⁢Doyon.

Can you summarize the key differences between regular blood⁤ and the potential “gold⁣ blood”?

| Feature⁤ ⁤ | Regular Blood ⁢ ⁢ ⁣ ⁢ ‍ ‍ ‍ | “Gold blood” (as per research)⁣ ‍ ‍ ⁤ ⁤ ⁤ |

| :—————— | :——————————————————- | :——————————————————— |

| Antigens ⁤ | Various antigens ‍determine blood type compatibility. ‍ | Genes associated with HR+ and AS antigens are inactivated. |

| Compatibility | Limited to specific blood types. ‍ ‍ ⁣ ⁢ | Potentially compatible with all blood groups (O- like). |

| Production Method | Relies on donated⁤ blood. ⁢ ‍ ‍ ⁤ | Produced in a lab using gene editing. ⁣ ⁤ ‍ ⁢ |

| Availability | Can be challenging ⁣for rare blood types or emergencies. | Potential for increased availability. ⁣ ⁣ ‍ |